Identification of hepatic, non-monoamine, dihydroergocryptine binding sites with significant gender differences

Life Sciences

Volumn 58, Issue 12, 1996, Pages 241-248

  Korneyev, Alexander Y ^a,b   Cincotta, Anthony H ^a  

^a Ergo Science Corp   (United States)

^b Ergoscience   (United States)

Author keywords

Bromocriptine; Dihydroergocryptine; Ergot alkaloids; Gender differences; Liver; Non monamine binding sites

Indexed keywords

CRICETINAE; ANIMALIA; MESOCRICETUS AURATUS;

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ADRENALIN; ALPHA ADRENERGIC RECEPTOR; ALPHA ERGOCRISTINE; BROMOCRIPTINE; BUTACLAMOL; DIHYDROERGOCRISTINE; DIHYDROERGOCRYPTINE; DIHYDROERGOTAMINE; DOMPERIDONE; DOPAMINE RECEPTOR; ERGOCORNINE; ERGOCRISTINE; ERGOT DERIVATIVE; ERGOTAMINE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NICARDIPINE; NITRENDIPINE; PHENTOLAMINE; PRAZOSIN; RADIOISOTOPE; ROTIGOTINE; SEROTONIN; SEROTONIN RECEPTOR; SPIPERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; YOHIMBINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; BRAIN; CONTROLLED STUDY; FEMALE; KIDNEY; LIGAND BINDING; LIVER MEMBRANE; LUNG; MALE; NONHUMAN; RAT; SCATCHARD PLOT; SEX DIFFERENCE; SPLEEN; SYRIAN HAMSTER;

ANIMALS; BINDING SITES; CRICETINAE; DIHYDROERGOTOXINE; FEMALE; HUMANS; KINETICS; LIVER; MALE; PHENTOLAMINE; RADIOLIGAND ASSAY; SEX FACTORS;

EID: 0029877162     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00053-7     Document Type: Article

References (13)

1. D.C. U'PRICHARD, Ergot Compounds and Brain Function, M Goldstein et al. (eds), 103-115, Raven Press, New York, 1980.
2. D.M. JACOBSON, N. MOHELL, J. GEORGIEV, A. BENGTSSON, L.-G. LARSSON, O. MAGNUSSON, S.B. ROSS, Naunyn-Schmiedeberg's Arch. Pharmacol. 315 146-155 (1995).
3. G. GUELLAEN, M. YATES-AGGERBECK, G. VAUQUELIN, D. STROSBERG, J. HANOUNE, J. Biol. Chem. 253 1114-1120 (1978).
4. W.R. CLARKE, L.R. JONES, R.J. LEFCOWITZ, J. Biol. Chem. 253 5975-5979 (1978).
5. M. EL-REFAI, P.F. BLACKMORE, J. EXTON, J. Biol. Chem. 254 4375-4379 (1979).
6. A.H. CINCOTTA, T.A. MacEACHERN, A.H. MEIER, Am. J. Physiol. 264 (Endocrino. Metab. 27) E285-E293 (1993).
7. A.H. CINCOTTA, A.H. MEIER, Metabolism 44 1349-1355 (1995).
8. B. BERGE, E. STURMER, Ergot Alcaloid and Related Compounds, B. Berge, H.O. Schild (Eds), 1-28, (1978).
9. L.C. TOLBERT, P.E. MORRIS Jr, J.J. SPOLLEN, S.C. ASHE, LIFE SCI. 51 921-930 (1992).
10. P. SEEMAN, Receptor Tables, Vol. 2, Drug Dissociation Constants for Neuroreceptors and Transporters, P. Seeman (Ed), Dopamine D2 receptors (1993).
11. C.F. NASSAR, E.G. KARKAJI, Z.M. HABBAL, M.G. NASSER, Gen. Pharmacol. 17 367-370 (1986).
12. M.F. EL-REFAI, J.H. EXTON, J. Biol. Chem. 255 5853-5858 (1980).
13. M.-A. PEYRONNEAU, M. DELAFORGE, R. RIVIERE, J.-P. RENAUD and D. MANSUY, Eur. J. Biochem. 223 947-956 (1994).